Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19

Sekine, Takuya, Perez-Potti, André, Rivera-Ballesteros, Olga, Strålin, Kristoffer, Gorin, Jean-Baptiste, Olsson, Annika, Llewellyn-Lacey, Sian, Kamal, Habiba +70 more·2020·Cell
DOI 10.1016/j.cell.2020.08.017

Cited by (1,002)

Items 501–600 of 1,002

  1. The impact of host resistance on cumulative mortality and the threshold of herd immunity for SARS-CoV-2
    José Lourenço, Francesco Pinotti, Craig Thompson, Sunetra Gupta · 2020 · medRxiv
  2. Risk prediction of COVID-19 incidence and mortality in a large multi-national hemodialysis cohort: implications for management of the pandemic in outpatient hemodialysis settings
    Mathias Loberg Haarhaus, Carla Santos-Araújo, Michael Haase, Pedro Mota Veiga, Carlos Lucas, Fernando Jose Gordinho Rocha M Macario · 2021 · Clinical Kidney Journal
  3. BNT162b2 mRNA COVID‐19 vaccine‐induced chilblain‐like lesions reinforces the hypothesis of their relationship with SARS‐CoV‐2
    Vincenzo Piccolo, Andrea Bassi, Giuseppe Argenziano, Carlo Mazzatenta, Mario Cutrone, Iria Neri, Ramón Grimalt, Teresa Palmira Russo · 2021 · Journal of the European Academy of Dermatology and Venereology
  4. Additive effects of booster mRNA vaccination and SARS-CoV-2 Omicron infection on T cell immunity across immunocompromised states
    Thomas R Müller, Takuya Sekine, Darya Trubach, Julia Niessl, Puran Chen, Peter Bergman, Ola Blennow, Lotta Hansson, Stephan Mielke, Piotr Nowak et al. · 2023 · Science Translational Medicine
  5. Rapid GMP-Compliant Expansion of SARS-CoV-2–Specific T Cells From Convalescent Donors for Use as an Allogeneic Cell Therapy for COVID-19
    Rachel S. Cooper, Alasdair R. Fraser, Linda M. Smith, Paul Burgoyne, Stuart N. Imlach, LISA M. JARVIS, David M. Turner, Sharon Zahra, Marc L. Turner, John D. Campbell · 2021 · Frontiers in Immunology
  6. Stringent thresholds in SARS-CoV-2 IgG assays lead to under-detection of mild infections
    David W. Eyre, Sheila Lumley, Denise O’Donnell, Nicole E Stoesser, Philippa Clare Matthews, Alison Howarth, Stephanie B. Hatch, Brian D. Marsden, Stuart Cox, Tim James et al. · 2021 · BMC Infectious Diseases
  7. Broad T Cell Targeting of Structural Proteins After SARS-CoV-2 Infection: High Throughput Assessment of T Cell Reactivity Using an Automated Interferon Gamma Release Assay
    Isabel Brand, Leonard Gilberg, Jan Bruger, Mercè Garí, Andreas Wieser, Tabea M. Eser, Jonathan Frese, Mohamed I. M. Ahmed, Raquel Rubio‐Acero, Jessica Michelle Guggenbuehl Noller et al. · 2021 · Frontiers in Immunology
  8. Generation of Glucocorticoid Resistant SARS-CoV-2 T-Cells for Adoptive Cell Therapy
    Rafet Başar, Nadima Uprety, Emily L. Ensley, May Daher, Kimberly L. Klein, Fernando D. Martínez, Fleur M. Aung, Mayra Shanley, Bingqian Hu, Elif Gokdemir et al. · 2020 · Cell Reports
  9. Severe Acute Respiratory Syndrome Coronavirus 2 Third Vaccine Immune Response in Multiple Sclerosis Patients Treated with Ocrelizumab
    Livnat Brill, Catarina Raposo, Ariel Rechtman, Omri Zveik, Netta Levin, Esther Oiknine‐Djian, Dana G. Wolf, Adi Vaknin‐Dembinsky · 2022 · Annals of Neurology
  10. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)–Specific T Cells and Antibodies in Coronavirus Disease 2019 (COVID-19) Protection: A Prospective Study
    Ivan A. Molodtsov, Evgenii Kegeles, Alexander N. Mitin, Olga N. Mityaeva, Oxana E. Musatova, Anna E. Panova, Mikhail V. Pashenkov, Iuliia O. Peshkova, Almaqdad Alsalloum, Walaa Asaad et al. · 2022 · Clinical Infectious Diseases
  11. Recurrence of COVID-19 associated with reduced T-cell responses in a monozygotic twin pair
    Mateus Vidigal de Castro, Keity Souza Santos, Juliana de Souza Apostólico, Edgar Ruz Fernandes, Rafael Ribeiro Almeida, Gabriel Levin, Jhosiene Yukari Magawa, João Paulo Silva Nunes, Mirian Bruni, Márcio Massao Yamamoto et al. · 2022 · Open Biology
  12. Accuracy of QuantiFERON SARS-CoV-2 research use only assay and characterization of the CD4+ and CD8+ T cell-SARS-CoV-2 response: comparison with a homemade interferon-γ release assay
    Alessandra Aiello, Andrea Coppola, Valentina Vanini, Linda Petrone, Gilda Cuzzi, Andrea Salmi, Anna Maria Gerarda Altera, Carla Tortorella, Gina Gualano, Claudio Gasperini et al. · 2022 · International Journal of Infectious Diseases
  13. Broad phenotypic alterations and potential dysfunction of lymphocytes in individuals clinically recovered from COVID-19
    Jingyi Yang, Maohua Zhong, Ejuan Zhang, Ke Hong, Qingyu Yang, Dihan Zhou, Jianbo Xia, Yao-Qing Chen, Mingbo Sun, Bali Zhao et al. · 2021 · Journal of Molecular Cell Biology
  14. Comparative immune profiling of acute respiratory distress syndrome patients with or without SARS-CoV-2 infection
    Mikaël Roussel, Juliette Ferrant, Florian Reizine, Simon Le Gallou, Joëlle Dulong, Sarah H. Carl, Matheiu Lesouhaitier, Murielle Grégoire, Nadège Bescher, Clotilde Verdy et al. · 2021 · Cell Reports Medicine
  15. Health literacy and changes in pattern of drug use among participants at the Stockholm Needle Exchange Program during the COVID-19 pandemic
    K. Lindqvist, C. Wallmofeldt, Elin Holmén, Anders Hammarberg, Martin Kåberg · 2021 · Harm Reduction Journal
  16. Prevalence and incidence of anti-SARS-CoV-2 antibodies among healthcare workers in Belgian hospitals before vaccination: a prospective cohort study
    Laure Mortgat, Kristien Verdonck, Veronik Hutse, Isabelle Thomas, Cyril Barbezange, Leo Heyndríckx, Natalie Fischer, Béa Vuylsteke, Ines Kabouche, Kevin K. Ariën et al. · 2021 · BMJ Open
  17. Host factors facilitating SARS‐CoV‐2 virus infection and replication in the lungs
    Sébastien Boutin, Dagmar Hildebrand, Steeve Boulant, Michael Kreuter, Jule Rüter, Srinivas Reddy Pallerla, Thirumalaisamy Palanichamy Velavan, Dennis Nurjadi · 2021 · Cellular and Molecular Life Sciences
  18. The impact of digital contact tracing on the SARS-CoV-2 pandemic—a comprehensive modelling study
    T. R. Pollmann, Julia Pollmann, Christoph Wiesinger, Christian Haack, L. Shtembari, A. Turcati, Birgit Neumair, Stephan Andrew Meighen-Berger, Giovanni Zattera, Birgit Neumair et al. · 2021 · EPJ Data Science
  19. T-cell responses to SARS-CoV-2 in multiple sclerosis patients treated with ocrelizumab healed from COVID-19 with absent or low anti-spike antibody titers
    Marco Iannetta, Doriana Landi, Gaia Cola, Vincenzo Malagnino, Elisabetta Teti, Daniela Fraboni, Francesco Buccisano, Sandro Grelli, Luigi Coppola, Laura Campogiani et al. · 2021 · Multiple Sclerosis and Related Disorders
  20. The Immune Response to SARS-CoV-2 and Variants of Concern
    Elham Torbati, Kurt L. Krause, James E. Ussher · 2021 · Viruses
  21. Immunogenic T cell epitopes of SARS-CoV-2 are recognized by circulating memory and naïve CD8 T cells of unexposed individuals
    Isaac Quiros‐Fernandez, Mansour Poorebrahim, Elham Fakhr, Ángel Cid-Arregui · 2021 · EBioMedicine
  22. mRNA COVID-19 Vaccines and Long-Lived Plasma Cells: A Complicated Relationship
    Girolamo Giannotta, Nicola Giannotta · 2021 · Vaccines
  23. CD8+ T-Cell Epitope Variations Suggest a Potential Antigen HLA-A2 Binding Deficiency for Spike Protein of SARS-CoV-2
    Congling Qiu, Chanchan Xiao, Zhigang Wang, Guodong Zhu, Lipeng Mao, Xiongfei Chen, Lijuan Gao, Jieping Deng, Jun Su, Huanxing Su et al. · 2022 · Frontiers in Immunology
  24. Children and Adults With Mild COVID-19: Dynamics of the Memory T Cell Response up to 10 Months
    Patricia Kaaijk, Veronica Olivo Pimentel, Maarten E. Emmelot, Martien C. M. Poelen, Alper Çevirgel, Rutger M. Schepp, Gerco den Hartog, Daphne F. M. Reukers, Lisa Beckers, Josine van Beek et al. · 2022 · Frontiers in Immunology
  25. Comparing the Nucleocapsid Proteins of Human Coronaviruses: Structure, Immunoregulation, Vaccine, and Targeted Drug
    Bo Zhang, Junjie Tian, Qintao Zhang, Yan Xie, Kejia Wang, Shuyi Qiu, Keyu Lu, Yang Liu · 2022 · Frontiers in Molecular Biosciences
  26. Evidence of previous SARS-CoV-2 infection in seronegative patients with long COVID
    Benjamin A. Krishna, Eleanor Y. Lim, Lenette Mactavous, Paul Lyons, Rainer Döffinger, John R. Bradley, Kenneth G. C. Smith, John H. Sinclair, Nicholas J. Matheson, Paul J. Lehner et al. · 2022 · EBioMedicine
  27. Limited Humoral and Specific T-Cell Responses After SARS-CoV-2 Vaccination in PWH With Poor Immune Reconstitution
    Susana Benet, Oscar Blanch-Lombarte, Erola Ainsua‐Enrich, Núria Pedreño-López, Jordana Muñoz‐Basagoiti, Dàlia Raïch Regué, Daniel Perez‐Zsolt, Ruth Peña, Esther Jímenez, Maria Luisa Rodrı́guez de la Concepción et al. · 2022 · The Journal of Infectious Diseases
  28. SARS-CoV-2 Related Antibody-Dependent Enhancement Phenomena In Vitro and In Vivo
    Emi E. Nakayama, Tatsuo Shioda · 2023 · Microorganisms
  29. Severe Acute Respiratory Syndrome Coronavirus 2
    M. Marks, Geraldine O'Hara, C. Houlihan, L. Bell, M. Heightman, Nicholas Hart · 2021 · Encyclopedia of Respiratory Medicine
  30. SARS -CoV-2 T-cell immunity to variants of concern following vaccination
    Kathleen Gallagher, Mark B. Leick, Rebecca C. Larson, Trisha R. Berger, Katelin Katsis, Jennifer Y. Yam, Gabrielle Brini, Korneel Grauwet, MGH COVID-19 Collection & Processing Team, Marcela Valderrama Maus · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  31. Identification of TCR repertoires in functionally competent cytotoxic T cells cross-reactive to SARS-CoV-2
    Kanako Shimizu, Tomonori Iyoda, An Sanpei, Hiroshi Nakazato, Masahiro Okada, Shogo Ueda, M. Kato-Murayama, Kazutaka Murayama, Mikako Shirouzu, Naoko Harada et al. · 2021 · Communications Biology
  32. Potential immune evasion of the severe acute respiratory syndrome coronavirus 2 Omicron variants
    Luyi Chen, Ying He, Hongye Liu, Yongjun Shang, Guoning Guo · 2024 · Frontiers in Immunology
  33. Incomplete humoral response including neutralizing antibodies in asymptomatic to mild COVID-19 patients in Japan
    Masaru Takeshita, Naoshi Nishina, Saya Moriyama, Yoshimasa Takahashi, Yoshifumi Uwamino, Mika Nagata, Wataru Aoki, Katsunori Masaki, Makoto Ishii, Hideyuki Saya et al. · 2021 · Virology
  34. Self-sampling of capillary blood for SARS-CoV-2 serology
    Lottie Brown, Rachel Louise Byrne, Alice J. Fraser, Sophie I. Owen, Ana I. Cubas-Atienzar, Christopher T. Williams, Grant A. Kay, Luís E. Cuevas, Joseph R A Fitchett, Tom E. Fletcher et al. · 2021 · Scientific Reports
  35. B- and T-cell immune responses elicited by the Comirnaty® COVID-19 vaccine in nursing-home residents
    Ignacio Torres, Eliseo Albert, Estela Giménez, María Jesús Alcaráz, Pilar Botija, Paula Amat, María José Remigia, María José Beltrán, Celia Rodado, Dixie Huntley et al. · 2021 · Clinical Microbiology and Infection
  36. Challenges and Scientific Prospects of the Newest Generation of mRNA-Based Vaccines against SARS-CoV-2
    Daniela Cornelia Călina, Antonio F. Hernández, Thomas Härtung, Alexey M. Egorov, Boris Nikolaevich Izotov, Τaxiarchis Κonstantinos Νikolouzakis, Aristidis Michael Tsatsakis, Panayiotis G. Vlachoyiannopoulos, Anca Oana Docea · 2021 · Life
  37. Rapid Development of Analytical Methods for Evaluating Pandemic Vaccines: A Covid-19 Perspective
    Jeremy Baldwin, Sakshi Piplani, Isaac G. Sakala, Yoshikazu Honda‐Okubo, Lei Li, Nikolai Petrovsky · 2021 · Bioanalysis
  38. Mass spectrometric identification of immunogenic SARS-CoV-2 epitopes and cognate TCRs
    Ke Pan, Yulun Chiu, Eric L. Huang, Michelle M. Chen, Junmei Wang, Ivy P. Lai, Shailbala Singh, Rebecca Shaw, Michael J. MacCoss, Cassian Yee · 2021 · Proceedings of the National Academy of Sciences
  39. Binding of phosphatidylserine‐positive microparticles by PBMCs classifies disease severity in COVID‐19 patients
    Lisa Rausch, Konstantin Lutz, Martina Schifferer, Elena Winheim, Rudi Gruber, Elina F. Oesterhaus, Linus Rinke, Johannes C. Hellmuth, Clemens Scherer, Maximilian Muenchhoff et al. · 2021 · Journal of Extracellular Vesicles
  40. COVID‐19 immunopathology with emphasis on Th17 response and cell‐based immunomodulation therapy: Potential targets and challenges
    Arash Pourgholaminejad, Saghar Pahlavanneshan, Mohsen Basiri · 2021 · Scandinavian Journal of Immunology
  41. Factors Associated With Serological Response to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Treated With Rituximab
    Andreas Tolf, Anna Wiberg, Malin Müller, Faisal Hayat Nazir, Ivan Pavlović, Ida Laurén, Sara M. Mangsbo, Joachim Burman · 2022 · JAMA Network Open
  42. Immunological memory to common cold coronaviruses assessed longitudinally over a three-year period pre-COVID19 pandemic
    Esther Dawen Yu, Tara M. Narowski, Eric W. Wang, Emily Garrigan, José Mateus, April Frazier, Daniela Weiskopf, Alba Grifoni, Lakshmanane Premkumar, Ricardo da Silva Antunes et al. · 2022 · Cell Host & Microbe
  43. Reactive T Cells in Convalescent COVID-19 Patients With Negative SARS-CoV-2 Antibody Serology
    Sophie Steiner, Tatjana Schwarz, Victor M. Corman, Franziska Sotzny, Sandra Bauer, Christian Drosten, Hans‐Dieter Volk, Carmen Scheibenbogen, Leif G. Hanitsch · 2021 · Frontiers in Immunology
  44. COVID-19: biologic and immunosuppressive therapy in gastroenterology and hepatology
    Markus Friedrich Neurath · 2021 · Nature Reviews Gastroenterology & Hepatology
  45. Immunological Profiling of COVID-19 Patients with Pulmonary Sequelae
    Jianghua Wu, Lu Tang, Yanling Ma, Yu Li, Dongmei Zhang, Qian Li, Heng Mei, Yu Hu · 2021 · mBio
  46. Commercial Interferon-gamma release assay to assess the immune response to first and second doses of mRNA vaccine in previously COVID-19 infected versus uninfected individuals
    Nuria Tormo, David Navalpotro, María Martínez-Serrano, Marta Moreno, Fernando Grosson, Irene Tur, Maria Remedios Guna, Pepa Soriano, Ana Tornero, Concepción Gimeno · 2021 · Diagnostic Microbiology and Infectious Disease
  47. Lasting Changes to Circulating Leukocytes in People with Mild SARS-CoV-2 Infections
    Allison E. Kennedy, Laura E. Cook, Jessica A. Breznik, Braeden Cowbrough, Jessica G. Wallace, Angela Huynh, James W. Smith, Kiho Son, Hannah D. Stacey, Jann Catherine Ang et al. · 2021 · Viruses
  48. Immune-Guided Therapy of COVID-19
    Gianfranco Ferraccioli, Elisa Gremese, Delia Goletti, Linda Petrone, Fabrizio Cantini, Stefano Ugel, Stefania Canè, Vincenzo Bronte · 2022 · Cancer Immunology Research
  49. Dominant CD8+ T Cell Nucleocapsid Targeting in SARS-CoV-2 Infection and Broad Spike Targeting From Vaccination
    Ellie Taus, Christian Hofmann, Francisco Javier Ibarrondo, Mary Ann Hausner, Jennifer A. Fulcher, Paul A Krogstad, Kathie G. Ferbas, Nicole H. Tobin, Anne W. Rimoin, Grace M. Aldrovandi et al. · 2022 · Frontiers in Immunology
  50. Persistence of Functional Memory B Cells Recognizing SARS-CoV-2 Variants Despite Loss of Specific IgG
    Stephan Winklmeier, Katharina Eisenhut, Damla Taskin, Heike Rübsamen, Ramona Gerhards, Celine Schneider, Paul R. Wratil, Marcel Stern, Peter Eichhorn, Oliver Till Keppler et al. · 2021 · iScience
  51. Immune responses to SARS‐CoV ‐2 vaccination in multiple sclerosis: a systematic review/meta‐analysis
    Grace Yoonheekim Gombolay, Monideep Dutt, William R. Tyor · 2022 · Annals of Clinical and Translational Neurology
  52. Post-vaccination T cell immunity to omicron
    Henning Jacobsen, Viviana Cobos Jiménez, Ioannis Sitaras, Naor Bar‐Zeev, Luka Čičin‐Šain, Melissa M. Higdon, Maria Deloria Knoll · 2022 · Frontiers in Immunology
  53. Mucosal COVID-19 vaccines: Risks, benefits and control of the pandemic
    Dimitrina Miteva, Monika Peshevska-Sekulovska, Violeta Snegarova, Hristiana Batselova, Radostina Alexandrova, Tsvetelina Veselinova Velikova · 2022 · World Journal of Virology
  54. Innate and adaptive immune response in SARS-CoV-2 infection-Current perspectives
    Qiugang Zhu, Yan Xu, Ting Wang, Feiting Xie · 2022 · Frontiers in Immunology
  55. A comprehensive review on the global efforts on vaccines and repurposed drugs for combating COVID-19
    Narva Deshwar Kushwaha, Jivanka Mohan, Babita Kushwaha, Terisha Ghazi, Joshua C. Nwabuife, Neil A. Koorbanally, Anil Amichund Chuturgoon · 2023 · European Journal of Medicinal Chemistry
  56. A Next Generation Bivalent Human Ad5 COVID-19 Vaccine Delivering Both Spike and Nucleocapsid Antigens Elicits Th1 Dominant CD4+, CD8+ T-cell and Neutralizing Antibody Responses
    Adrian Rice, Mohit S. Verma, Annie Shin, Lise Zakin, Peter A. Sieling, Shiho Tanaka, Helty Adisetiyo, Justin D. Taft, Roosheel S. Patel, Sofija Buta et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  57. Increased Complement Receptor-3 levels in monocytes and granulocytes distinguish COVID-19 patients with pneumonia from those with mild symptoms
    Rajeev Gupta, Vanya A. Gant, Bryan Williams, Tariq Enver · 2020 · International Journal of Infectious Diseases
  58. T cell phenotypes in COVID-19 - a living review
    Stephanie Jean Hanna, Amy Susan Codd, Ester Gea‐Mallorquí, David Oliver Scourfield, Felix Clemens Richter, Kristin Ladell, Mariana Borsa, Ewoud Bernardus Compeer, Owen R. Moon, Sarah A. E. Galloway et al. · 2020 · Oxford Open Immunology
  59. Five Commercial Immunoassays for SARS-CoV-2 Antibody Determination and Their Comparison and Correlation with the Virus Neutralization Test
    Václav Šimánek, Ladislav Pecen, Zuzana Krátká, Tomáš Fürst, Hana Řezáčková, Ondřej Topolčan, Karel Fajfrlík, Dalibor Sedláček, Robin Šín, Petr Pazdiora et al. · 2021 · Diagnostics
  60. Young infants exhibit robust functional antibody responses and restrained IFN-γ production to SARS-CoV-2
    Anu Goenka, Alice Halliday, Michaela Gregorová, Emily Milodowski, Amy C Thomas, Maia Kavanagh Williamson, Holly E. Baum, Elizabeth Oliver, Anna E. Long, Lea Knežević et al. · 2021 · Cell Reports Medicine
  61. Longitudinal analysis of antibody decay in convalescent COVID-19 patients
    Weiming Xia, Mingfei Li, Ying Wang, Lewis E. Kazis, Kim Berlo, Noureddine Melikechi, Gregory R. Chiklis · 2021 · Scientific Reports
  62. Generation of potent cellular and humoral immunity against SARS-CoV-2 antigens via conjugation to a polymeric glyco-adjuvant
    Laura T. Gray, Michal M. Raczy, Priscilla S. Briquez, Tiffany M. Marchell, Aaron T. Alpar, Rachel P. Wallace, Lisa R. Volpatti, Maria Stella Sasso, Shijie Cao, Mindy Nguyen et al. · 2021 · Biomaterials
  63. A Tale of Three Recent Pandemics: Influenza, HIV and SARS-CoV-2
    Mafalda Miranda, Marta Pingarilho, Victor Pimentel, Andrea Torneri, Sofia G. Seabra, Pieter Libin, Ana Barroso Abecasis · 2022 · Frontiers in Microbiology
  64. The Role of Cellular Immunity in the Protective Efficacy of the SARS-CoV-2 Vaccines
    Zhongjie Sun, Tingxin Wu, Huangfan Xie, Yuhuan Li, Jinlan Zhang, Xun‐Cheng Su, Hailong Qi · 2022 · Vaccines
  65. High antibody levels and reduced cellular response in children up to one year after SARS-CoV-2 infection
    Eva‐Maria Jacobsen, Dorit Fabricius, Magdalena Class, Fernando Topfstedt, Raquel Lorenzetti, Iga Janowska, Franziska Schmidt, Julian Staniek, Maria Zernickel, Thomas Stamminger et al. · 2022 · Nature Communications
  66. DNA origami vaccine nanoparticles improve humoral and cellular immune responses to infectious diseases
    Yang C. Zeng, Olivia J. Young, Qiancheng Xiong, Longlong Si, Min‐Wen Ku, Sylvie G. Bernier, Hawa Dembele, Giorgia Isinelli, Tal Gilboa, Zoe Swank et al. · 2026 · Nature Biomedical Engineering
  67. Considering Interim Interventions to Control COVID-19 Associated Morbidity and Mortality—Perspectives
    Mark Christopher Arokiaraj · 2020 · Frontiers in Public Health
  68. COVID-19: The Emerging Immunopathological Determinants for Recovery or Death
    Tanveer Ahmad, Rituparna Chaudhuri, Mohan Chandra Joshi, Ahmad Almatroudi, Arshad Husain Rahmani, Syed Mansoor Ali · 2020 · Frontiers in Microbiology
  69. COVID-19 and Dentistry in 72 Questions: An Overview of the Literature
    Stéphane Derruau, Jérôme Bouchet, Ali Nassif, Alexandre Baudet, Kazutoyo Yasukawa, Sandrine Lorimier, Isabelle Prêcheur, Agnès Bloch‐Zupan, B. Pellat, Hélène Chardin et al. · 2021 · Journal of Clinical Medicine
  70. Perspective: diagnostic laboratories should urgently develop T cell assays for SARS-CoV-2 infection
    Rohan Ameratunga, See‐Tarn Woon, Anthony Jordan, Hilary J Longhurst, Euphemia Yee Leung, Richard Henderson Steele, Klaus Lehnert, Russell G. Snell, Anna E. S. Brooks · 2021 · Expert Review of Clinical Immunology
  71. Embryonic Origin and Subclonal Evolution of Tumor-Associated Macrophages Imply Preventive Care for Cancer
    Xiaomei Zhang, De-Gao Chen, Shengwen Calvin Li, Bo Zhu, Zhongjun Li · 2021 · Cells
  72. CD4+ T cells from COVID-19 mRNA vaccine recipients recognize a conserved epitope present in diverse coronaviruses
    Bezawit A. Woldemeskel, Arbor G. Dykema, Caroline C. Garliss, Saphira Cherfils, Kellie Nicole Smith, Joel N. Blankson · 2022 · Journal of Clinical Investigation
  73. Alterations in SARS-CoV-2 Omicron and Delta peptides presentation by HLA molecules
    Stepan A. Nersisyan, Anton Zhiyanov, Maria Zakharova, Irina A. Ishina, Inna N. Kurbatskaia, Azad E. Mamedov, Alexei Vladimirovich Galatenko, M. Yu. Shkurnikov, Alexander G. Gabibov, Alexander Tonevitsky · 2022 · PeerJ
  74. A novel vaccine based on SARS-CoV-2 CD4+ and CD8+ T cell conserved epitopes from variants Alpha to Omicron
    Iam Palatnik de Sousa, Zachary S. Wallace, Stephany Christiny Cavalcante, Maria Paula Fonseca Ribeiro, João Antônio Barbosa Martins Silva, Rafael Ciro Marques Cavalcante, Richard H. Scheuermann, M Palatnik · 2022 · Scientific Reports
  75. CD8+ T-cell immune escape by SARS-CoV-2 variants of concern
    Arnaud John Kombe Kombe, Fleury Augustin Nsole Biteghe, Zélia Nelly Ndoutoume, Tengchuan Jin · 2022 · Frontiers in Immunology
  76. Early peripheral blood MCEMP1 and HLA-DRA expression predicts COVID-19 prognosis
    Kuan Rong Chan, Clara WT Koh, Dorothy Hui Lin Ng, Shijie Qin, Justin S. G. Ooi, Eugenia Ziying Ong, Summer L.X. Zhang, Huizhen Sam, Shirin Kalimuddin, Jenny Guek Hong Low et al. · 2023 · EBioMedicine
  77. SARS-CoV-2: Immunity, Challenges with Current Vaccines, and a Novel Perspective on Mucosal Vaccines
    Raju Sunagar, Amit Singh, Sudeep Kumar · 2023 · Vaccines
  78. Human coronavirus OC43-elicited CD4+ T cells protect against SARS-CoV-2 in HLA transgenic mice
    Rúbens Prince dos Santos Alves, Julia Timis, Robyn Miller, Kristen M. Valentine, Paolla Beatriz Almeida Pinto, Andrew Gonzalez, José Ángel Regla-Nava, Erin Maule, Michael N. Nguyen, Norazizah Shafee et al. · 2024 · Nature Communications
  79. Is a healthy microbiome responsible for lower mortality in COVID-19?
    Ľubomír Janda, Matúš Mihalčin, Michaela Šťastná · 2020 · Biologia
  80. Antibody response to mRNA SARS-CoV-2 vaccines in haemodialysis patients
    Michael Paal, Florian M. Arend, Tobias Lau, Sandra E. Hasmann, Daniela Soreth-Rieke, Johanna Sorodoc-Otto, Wilke Beuthien, Julia Krappe, Marcell Toepfer, Gero von Gersdorff et al. · 2021 · Clinical Kidney Journal
  81. Systems Thinking About SARS-CoV-2
    Rainer J. Klement · 2020 · Frontiers in Public Health
  82. Current COVID-19 vaccine candidates: Implications in the Saudi population
    AlAnoud TofailAhmed Rajah, Aws Alshamsan, Ahmed H. Al-Jedai · 2020 · Saudi Pharmaceutical Journal
  83. Population-Based Serosurvey for Severe Acute Respiratory Syndrome Coronavirus 2 Transmission, Chennai, India
    Sriram Selvaraju, Muthusamy Santhosh Kumar, Jeromie Wesley Vivian Thangaraj, Tarun Bhatnagar, Saravanakumar Velusamy, C. P. Girish Kumar, Krithikaa Sekar, Ezhilarasan Ilayaperumal, Ramasamy Sabarinathan, Murugesan Jagadeesan et al. · 2021 · Emerging infectious diseases
  84. Validation of a commercially available indirect assay for SARS-CoV-2 neutralising antibodies using a pseudotyped virus assay
    Matthew J Murray, Megan McIntosh, Claire E. Atkinson, Tabitha W. Mahungu, Edward Wright, Wendy Chatterton, Michael Gandy, Matthew B. Reeves · 2021 · Journal of Infection
  85. Dynamics of the seroprevalence of SARS-CoV-2 antibodies among healthcare workers at a COVID-19 referral hospital in Milan, Italy
    Laura Milazzo, Alessia Lai, Laura Pezzati, Letizia M Oreni, Annalisa Bergna, Federico Conti, Cristina Meroni, Davide Minisci, Massimo Galli, Mario Corbellino et al. · 2021 · Occupational and Environmental Medicine
  86. Age, Disease Severity and Ethnicity Influence Humoral Responses in a Multi-Ethnic COVID-19 Cohort
    Muneerah Smith, Houari Abdesselem, Michelle O. Mullins, Ti-Myen Tan, Andrew J. M. Nel, Maryam Ali Al‐Nesf, Ilham Bensmail, Nour K. Majbour, Nishant N. Vaikath, Adviti Naik et al. · 2021 · Viruses
  87. Deconvoluting the T Cell Response to SARS-CoV-2: Specificity Versus Chance and Cognate Cross-Reactivity
    Alexander A. Lehmann, Greg A. Kirchenbaum, Ting Zhang, Pedro Antonio Reche, Paul Lehmann · 2021 · Frontiers in Immunology
  88. Immunothrombosis in Acute Respiratory Dysfunction of COVID-19
    Xiang-Zhi Fang, Ya-Xin Wang, Ji-Qain Xu, Ya-Jun He, Zhe-Kang Peng, You Shang · 2021 · Frontiers in Immunology
  89. Persistent Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Immunocompromised Host Displaying Treatment Induced Viral Evolution
    Ida Monrad, Signe Risgaard Sahlertz, Stine Sofie Frank Nielsen, Louise Ørnskov Pedersen, Mikkel Steen Petersen, Carl Mathias Kobel, Irene Harder Tarpgaard, Merete Storgaard, Klaus Leth Mortensen, Mariane Høgsbjerg Schleimann et al. · 2021 · Open Forum Infectious Diseases
  90. Single-cell analysis reveals cell communication triggered by macrophages associated with the reduction and exhaustion of CD8+ T cells in COVID-19
    Lei He, Quan Zhang, Yue Zhang, Yixian Fan, Fahu Yuan, Songming Li · 2021 · Cell Communication and Signaling
  91. What Happens to the Immune System after Vaccination or Recovery from COVID-19?
    Bruna Tiaki Tiyo, Gabriela J. H. Schmitz, Marina Mazzilli Ortega, Laís T. da Silva, Alexandre de Almeida, Telma Miyuki Oshiro, Alberto José da Silva Duarte · 2021 · Life
  92. Whole‐blood cytokine secretion assay as a high‐throughput alternative for assessing the cell‐mediated immunity profile after two doses of an adjuvanted SARS‐CoV‐2 recombinant protein vaccine candidate
    Stephen C. De Rosa, Kristen W. Cohen, Matthew I Bonaparte, Bo Fu, Sanjay Garg, Catherine M. Gerard, Paul Goepfert, Ying Huang, Daniel Larocque, M. Juliana McElrath et al. · 2022 · Clinical & Translational Immunology
  93. Identification of Distinct Immune Cell Subsets Associated With Asymptomatic Infection, Disease Severity, and Viral Persistence in COVID-19 Patients
    Xiaorui Wang, Han Bai, Junpeng Ma, Hongyu Qin, Qiqi Zeng, Fang Hu, Tingting Jiang, Weikang Mao, Yang Zhao, Xiaobei Chen et al. · 2021 · Frontiers in Immunology
  94. Characterization of memory T cell subsets and common γ−chain cytokines in convalescent COVID-19 individuals
    Anuradha Rajamanickam, Nathella Pavan Kumar, Arul Nancy Pandiaraj, Nandhini Selvaraj, Saravanan Munisankar, Rachel Mariam Renji, Vijayalakshmi Venkataramani, Manoj Murhekar, Jeromie Wesley Vivian Thangaraj, Santhosh Kumar Muthusamy et al. · 2022 · Journal of Leukocyte Biology
  95. Sex, Age, and Ethnic Background Shape Adaptive Immune Responses Induced by the SARS-CoV-2 mRNA Vaccine
    Jie Bai, Asako Chiba, Goh Murayama, Taiga Kuga, Naoto Tamura, Sachiko Miyake · 2022 · Frontiers in Immunology
  96. Immunogenicity and efficacy of Ad26. COV2 .S: An adenoviral vector–based COVID ‐19 vaccine
    Mathieu Le Gars, Jenny Hendriks, JERALD C. SADOFF, Martin Ryser, Frank Struyf, Macaya Douoguih, Hanneke Schuitemaker · 2022 · Immunological Reviews
  97. How I treat and prevent COVID-19 in patients with hematologic malignancies and recipients of cellular therapies
    Firas El Chaer, Jeffery James Auletta, Roy F. Chemaly · 2022 · Blood
  98. Persistent Maintenance of Intermediate Memory B Cells Following SARS-CoV-2 Infection and Vaccination Recall Response
    Jernej Pušnik, Julia König, Karola Mai, Enrico Richter, Jasmin Zorn, Hannah Proksch, Bianca Schulte, Galit Alter, Hendrik Streeck · 2022 · Journal of Virology
  99. Attenuated humoral responses in HIV after SARS-CoV-2 vaccination linked to B cell defects and altered immune profiles
    E. Touizer, Aljawharah Alrubayyi, R. Ford, N. Hussain, P. Gerber, Hiu-Long Shum, C. Rees-Spear, L. Muir, E. Gea-Mallorquí, J. Kopycinski et al. · 2022 · iScience
  100. Dynamic SARS-CoV-2-Specific Immunity in Critically Ill Patients With Hypertension
    Qiang Zeng, Yongzhe Li, Sheng-Yong Dong, Zongtao Chen, Xiangyang Gao, Han Zhang, Gang Huang, Yang Xu · 2020 · Frontiers in Immunology